{"transactions":[{"id":697238,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-08-04T20:40:33.000Z","date":"2026-08-01","kind":"exercise","planned":false,"acquired":false,"shares":403,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested immediately upon grant on August 1, 2026; there was no expiration date for the RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested immediately upon grant on August 1, 2026; there was no expiration date for the RSUs."}],"balance_after":0,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":403},"source":{"system":"sec-edgar","filing":"0001454983-26-000008","document":"form4-08042026_080829.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000145498326000008/form4-08042026_080829.xml","form_type":"4"}},{"id":697237,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-08-04T20:40:33.000Z","date":"2026-08-01","kind":"grant","planned":false,"acquired":true,"shares":403,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested immediately upon grant on August 1, 2026; there was no expiration date for the RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested immediately upon grant on August 1, 2026; there was no expiration date for the RSUs."}],"balance_after":403,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":403},"source":{"system":"sec-edgar","filing":"0001454983-26-000008","document":"form4-08042026_080829.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000145498326000008/form4-08042026_080829.xml","form_type":"4"}},{"id":697236,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Share","published_at":"2026-08-04T20:40:33.000Z","date":"2026-08-01","kind":"exercise","planned":false,"acquired":true,"shares":403,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":22359,"source":{"system":"sec-edgar","filing":"0001454983-26-000008","document":"form4-08042026_080829.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000145498326000008/form4-08042026_080829.xml","form_type":"4"}},{"id":717827,"issuer":{"id":4388,"kind":"organization","name":"Kodiak Sciences Inc."},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-02T21:55:34.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":17731,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One hundred percent (100%) of the shares subject to the option shall vest upon the earlier of June 30, 2027 or one (1) day prior to the Issuer's next annual meeting occurring after the grant date, in each case, provided the Reporting Person continues to serve as a member of the Issuer's board of directors through the applicable vesting date."}],"balance_after":17731,"derivative":{"exercise_price":38.96,"expiration_date":"2036-06-29","underlying":"Common Stock","underlying_shares":17731},"source":{"system":"sec-edgar","filing":"0001454983-26-000006","document":"form4-07022026_090730.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468748/000145498326000006/form4-07022026_090730.xml","form_type":"4"}},{"id":732522,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-18T20:21:50.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":766,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests as to 100% of underlying shares on the earlier of (i) June 17, 2027 and (ii) the date of the Issuer's annual meeting of stockholders to be held in 2027, provided the Reporting Person continues in service with the Issuer on such date."}],"balance_after":766,"derivative":{"exercise_price":499.86,"expiration_date":"2036-06-17","underlying":"Common Stock","underlying_shares":766},"source":{"system":"sec-edgar","filing":"0001628280-26-044340","document":"wk-form4_1781814108.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026044340/wk-form4_1781814108.xml","form_type":"4"}},{"id":732521,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-18T20:21:50.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":454,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units which vest on the earlier of (i) June 17, 2027 and (ii) the date of the Issuer's annual meeting of stockholders to be held in 2027, provided the Reporting Person continues in service with the Issuer on such date."}],"balance_after":22469,"source":{"system":"sec-edgar","filing":"0001628280-26-044340","document":"wk-form4_1781814108.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026044340/wk-form4_1781814108.xml","form_type":"4"}},{"id":736090,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-16T20:05:24.000Z","date":"2026-06-15","kind":"grant","planned":false,"acquired":true,"shares":31000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1. The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control."}],"balance_after":31000,"derivative":{"exercise_price":3.94,"exercise_date":"2027-06-15","expiration_date":"2036-06-14","underlying":"Common Stock","underlying_shares":31000},"source":{"system":"sec-edgar","filing":"0001213900-26-069250","document":"marketforms-73187.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1454983/000121390026069250/marketforms-73187.xml","form_type":"4"}},{"id":754844,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-06-02T20:44:23.000Z","date":"2026-05-29","kind":"exercise","planned":false,"acquired":false,"shares":2799,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vested in a single installment on May 29, 2026; there was no expiration date for the RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vested in a single installment on May 29, 2026; there was no expiration date for the RSUs."}],"balance_after":0,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":2799},"source":{"system":"sec-edgar","filing":"0001454983-26-000004","document":"form4-06022026_080618.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000145498326000004/form4-06022026_080618.xml","form_type":"4"}},{"id":754843,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-06-02T20:44:23.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":2026,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in their entirety on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is May 29, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in their entirety on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is May 29, 2026."}],"balance_after":2026,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":2026},"source":{"system":"sec-edgar","filing":"0001454983-26-000004","document":"form4-06022026_080618.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000145498326000004/form4-06022026_080618.xml","form_type":"4"}},{"id":754842,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option","published_at":"2026-06-02T20:44:23.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":12158,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of the grant with the final installment vesting on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is May 29, 2026."}],"balance_after":12158,"derivative":{"exercise_price":48.38,"expiration_date":"2036-05-28","underlying":"Class A Ordinary Shares","underlying_shares":12158},"source":{"system":"sec-edgar","filing":"0001454983-26-000004","document":"form4-06022026_080618.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000145498326000004/form4-06022026_080618.xml","form_type":"4"}},{"id":754841,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Share","published_at":"2026-06-02T20:44:23.000Z","date":"2026-05-29","kind":"exercise","planned":false,"acquired":true,"shares":2799,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":21956,"source":{"system":"sec-edgar","filing":"0001454983-26-000004","document":"form4-06022026_080618.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000145498326000004/form4-06022026_080618.xml","form_type":"4"}},{"id":766476,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-22T22:01:53.000Z","date":"2026-05-22","kind":"sale","planned":true,"acquired":false,"shares":80,"price":519.98,"value":41598.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 20, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $519.68 to $520.28, inclusive."}],"balance_after":22015,"source":{"system":"sec-edgar","filing":"0001628280-26-037830","document":"wk-form4_1779487311.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026037830/wk-form4_1779487311.xml","form_type":"4"}},{"id":766475,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-22T22:01:53.000Z","date":"2026-05-22","kind":"sale","planned":true,"acquired":false,"shares":782,"price":518.758,"value":405668.756,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 20, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $518.30 to $519.29, inclusive."}],"balance_after":22095,"source":{"system":"sec-edgar","filing":"0001628280-26-037830","document":"wk-form4_1779487311.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026037830/wk-form4_1779487311.xml","form_type":"4"}},{"id":766474,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-22T22:01:53.000Z","date":"2026-05-22","kind":"sale","planned":true,"acquired":false,"shares":1497,"price":517.5921,"value":774835.3737,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 20, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $517.28 to $518.27, inclusive."}],"balance_after":22877,"source":{"system":"sec-edgar","filing":"0001628280-26-037830","document":"wk-form4_1779487311.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026037830/wk-form4_1779487311.xml","form_type":"4"}},{"id":766473,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-22T22:01:53.000Z","date":"2026-05-22","kind":"sale","planned":true,"acquired":false,"shares":723,"price":516.8658,"value":373693.9734,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 20, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $516.28 to $517.27, inclusive."}],"balance_after":24374,"source":{"system":"sec-edgar","filing":"0001628280-26-037830","document":"wk-form4_1779487311.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026037830/wk-form4_1779487311.xml","form_type":"4"}},{"id":766472,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-22T22:01:53.000Z","date":"2026-05-22","kind":"sale","planned":true,"acquired":false,"shares":657,"price":515.9219,"value":338960.6883,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 20, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $515.26 to $516.22, inclusive."}],"balance_after":25097,"source":{"system":"sec-edgar","filing":"0001628280-26-037830","document":"wk-form4_1779487311.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026037830/wk-form4_1779487311.xml","form_type":"4"}},{"id":766471,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-22T22:01:53.000Z","date":"2026-05-22","kind":"sale","planned":true,"acquired":false,"shares":343,"price":514.6691,"value":176531.5013,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 20, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $514.17 to $515.16, inclusive."}],"balance_after":25754,"source":{"system":"sec-edgar","filing":"0001628280-26-037830","document":"wk-form4_1779487311.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026037830/wk-form4_1779487311.xml","form_type":"4"}},{"id":766470,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-22T22:01:53.000Z","date":"2026-05-22","kind":"sale","planned":true,"acquired":false,"shares":40,"price":512.97,"value":20518.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 20, 2026."}],"balance_after":26097,"source":{"system":"sec-edgar","filing":"0001628280-26-037830","document":"wk-form4_1779487311.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026037830/wk-form4_1779487311.xml","form_type":"4"}},{"id":766469,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-22T22:01:53.000Z","date":"2026-05-22","kind":"sale","planned":true,"acquired":false,"shares":439,"price":512.5022,"value":224988.4658,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 20, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $511.91 to $512.88, inclusive."}],"balance_after":26137,"source":{"system":"sec-edgar","filing":"0001628280-26-037830","document":"wk-form4_1779487311.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026037830/wk-form4_1779487311.xml","form_type":"4"}},{"id":766468,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-22T22:01:53.000Z","date":"2026-05-22","kind":"sale","planned":true,"acquired":false,"shares":610,"price":511.3967,"value":311951.987,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 20, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $510.89 to $511.87, inclusive."}],"balance_after":26576,"source":{"system":"sec-edgar","filing":"0001628280-26-037830","document":"wk-form4_1779487311.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026037830/wk-form4_1779487311.xml","form_type":"4"}},{"id":766467,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-22T22:01:53.000Z","date":"2026-05-22","kind":"sale","planned":true,"acquired":false,"shares":151,"price":510.3579,"value":77064.0429,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 20, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $509.89 to $510.85, inclusive."}],"balance_after":27186,"source":{"system":"sec-edgar","filing":"0001628280-26-037830","document":"wk-form4_1779487311.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026037830/wk-form4_1779487311.xml","form_type":"4"}},{"id":766466,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-22T22:01:53.000Z","date":"2026-05-22","kind":"sale","planned":true,"acquired":false,"shares":320,"price":508.242,"value":162637.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 20, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $508.11 to $508.89, inclusive."}],"balance_after":27337,"source":{"system":"sec-edgar","filing":"0001628280-26-037830","document":"wk-form4_1779487311.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026037830/wk-form4_1779487311.xml","form_type":"4"}},{"id":766465,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-22T22:01:53.000Z","date":"2026-05-22","kind":"sale","planned":true,"acquired":false,"shares":40,"price":506.675,"value":20267.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 20, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $506.42 to $507.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below."}],"balance_after":27657,"source":{"system":"sec-edgar","filing":"0001628280-26-037830","document":"wk-form4_1779487311.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026037830/wk-form4_1779487311.xml","form_type":"4"}},{"id":885573,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-24T22:09:06.000Z","date":"2026-02-23","kind":"exercise","planned":false,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":7.36,"expiration_date":"2026-08-11","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001628280-26-011211","document":"wk-form4_1771970943.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026011211/wk-form4_1771970943.xml","form_type":"4"}},{"id":885572,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-24T22:09:06.000Z","date":"2026-02-23","kind":"exercise","planned":false,"acquired":true,"shares":2500,"price":7.36,"value":18400.0,"ownership":{"direct":true},"balance_after":27697,"source":{"system":"sec-edgar","filing":"0001628280-26-011211","document":"wk-form4_1771970943.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026011211/wk-form4_1771970943.xml","form_type":"4"}},{"id":919453,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-02-04T23:20:58.000Z","date":"2026-02-01","kind":"exercise","planned":false,"acquired":false,"shares":683,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested immediately upon grant on February 1, 2026; there was no expiration date for the RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested immediately upon grant on February 1, 2026; there was no expiration date for the RSUs."}],"balance_after":0,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":683},"source":{"system":"sec-edgar","filing":"0001454983-26-000002","document":"form4-02042026_110254.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000145498326000002/form4-02042026_110254.xml","form_type":"4"}},{"id":919452,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-02-04T23:20:58.000Z","date":"2026-02-01","kind":"grant","planned":false,"acquired":true,"shares":683,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested immediately upon grant on February 1, 2026; there was no expiration date for the RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested immediately upon grant on February 1, 2026; there was no expiration date for the RSUs."}],"balance_after":683,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":683},"source":{"system":"sec-edgar","filing":"0001454983-26-000002","document":"form4-02042026_110254.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000145498326000002/form4-02042026_110254.xml","form_type":"4"}},{"id":919451,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Share","published_at":"2026-02-04T23:20:58.000Z","date":"2026-02-01","kind":"exercise","planned":false,"acquired":true,"shares":683,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":19157,"source":{"system":"sec-edgar","filing":"0001454983-26-000002","document":"form4-02042026_110254.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000145498326000002/form4-02042026_110254.xml","form_type":"4"}},{"id":931348,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-26T23:02:25.000Z","date":"2026-01-26","kind":"exercise","planned":false,"acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":16.46,"expiration_date":"2027-06-29","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001628280-26-003491","document":"wk-form4_1769468543.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026003491/wk-form4_1769468543.xml","form_type":"4"}},{"id":931347,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-26T23:02:25.000Z","date":"2026-01-26","kind":"exercise","planned":false,"acquired":true,"shares":4000,"price":16.46,"value":65840.0,"ownership":{"direct":true},"balance_after":25197,"source":{"system":"sec-edgar","filing":"0001628280-26-003491","document":"wk-form4_1769468543.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026003491/wk-form4_1769468543.xml","form_type":"4"}},{"id":999169,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-14T22:12:26.000Z","date":"2025-11-13","kind":"exercise","planned":true,"acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F15","text":"The shares underlying this option are fully vested and exercisable."}],"balance_after":4000,"derivative":{"exercise_price":16.46,"expiration_date":"2027-06-29","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001628280-25-052411","document":"wk-form4_1763158342.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025052411/wk-form4_1763158342.xml","form_type":"4"}},{"id":999168,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-14T22:12:26.000Z","date":"2025-11-13","kind":"exercise","planned":true,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F15","text":"The shares underlying this option are fully vested and exercisable."}],"balance_after":2500,"derivative":{"exercise_price":7.36,"expiration_date":"2026-08-11","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001628280-25-052411","document":"wk-form4_1763158342.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025052411/wk-form4_1763158342.xml","form_type":"4"}},{"id":999167,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-14T22:12:26.000Z","date":"2025-11-13","kind":"sale","planned":true,"acquired":false,"shares":40,"price":530.21,"value":21208.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2025."}],"balance_after":21197,"source":{"system":"sec-edgar","filing":"0001628280-25-052411","document":"wk-form4_1763158342.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025052411/wk-form4_1763158342.xml","form_type":"4"}},{"id":999166,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-14T22:12:26.000Z","date":"2025-11-13","kind":"sale","planned":true,"acquired":false,"shares":440,"price":528.6036,"value":232585.584,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F14","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $528.18 to $528.94, inclusive."}],"balance_after":21237,"source":{"system":"sec-edgar","filing":"0001628280-25-052411","document":"wk-form4_1763158342.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025052411/wk-form4_1763158342.xml","form_type":"4"}},{"id":999165,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-14T22:12:26.000Z","date":"2025-11-13","kind":"sale","planned":true,"acquired":false,"shares":200,"price":527.8484,"value":105569.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $527.17 to $528.15, inclusive."}],"balance_after":21677,"source":{"system":"sec-edgar","filing":"0001628280-25-052411","document":"wk-form4_1763158342.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025052411/wk-form4_1763158342.xml","form_type":"4"}},{"id":999164,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-14T22:12:26.000Z","date":"2025-11-13","kind":"sale","planned":true,"acquired":false,"shares":120,"price":526.683,"value":63201.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $526.17 to $527.09, inclusive."}],"balance_after":21877,"source":{"system":"sec-edgar","filing":"0001628280-25-052411","document":"wk-form4_1763158342.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025052411/wk-form4_1763158342.xml","form_type":"4"}},{"id":999163,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-14T22:12:26.000Z","date":"2025-11-13","kind":"sale","planned":true,"acquired":false,"shares":153,"price":524.4905,"value":80247.0465,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $524.31 to $524.71, inclusive."}],"balance_after":21997,"source":{"system":"sec-edgar","filing":"0001628280-25-052411","document":"wk-form4_1763158342.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025052411/wk-form4_1763158342.xml","form_type":"4"}},{"id":999162,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-14T22:12:26.000Z","date":"2025-11-13","kind":"sale","planned":true,"acquired":false,"shares":811,"price":523.6589,"value":424687.3679,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $523.31 to $524.29, inclusive."}],"balance_after":22150,"source":{"system":"sec-edgar","filing":"0001628280-25-052411","document":"wk-form4_1763158342.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025052411/wk-form4_1763158342.xml","form_type":"4"}},{"id":999161,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-14T22:12:26.000Z","date":"2025-11-13","kind":"sale","planned":true,"acquired":false,"shares":1434,"price":522.7037,"value":749557.1058,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $522.30 to $523.29, inclusive."}],"balance_after":22961,"source":{"system":"sec-edgar","filing":"0001628280-25-052411","document":"wk-form4_1763158342.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025052411/wk-form4_1763158342.xml","form_type":"4"}},{"id":999160,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-14T22:12:26.000Z","date":"2025-11-13","kind":"sale","planned":true,"acquired":false,"shares":1094,"price":521.7877,"value":570835.7438,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $521.22 to $522.21, inclusive."}],"balance_after":24395,"source":{"system":"sec-edgar","filing":"0001628280-25-052411","document":"wk-form4_1763158342.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025052411/wk-form4_1763158342.xml","form_type":"4"}},{"id":999159,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-14T22:12:26.000Z","date":"2025-11-13","kind":"sale","planned":true,"acquired":false,"shares":308,"price":520.6798,"value":160369.3784,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $520.21 to $521.18, inclusive."}],"balance_after":25489,"source":{"system":"sec-edgar","filing":"0001628280-25-052411","document":"wk-form4_1763158342.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025052411/wk-form4_1763158342.xml","form_type":"4"}},{"id":999158,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-14T22:12:26.000Z","date":"2025-11-13","kind":"sale","planned":true,"acquired":false,"shares":1355,"price":519.6654,"value":704146.617,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $519.18 to $520.15, inclusive."}],"balance_after":25797,"source":{"system":"sec-edgar","filing":"0001628280-25-052411","document":"wk-form4_1763158342.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025052411/wk-form4_1763158342.xml","form_type":"4"}},{"id":999157,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-14T22:12:26.000Z","date":"2025-11-13","kind":"sale","planned":true,"acquired":false,"shares":835,"price":518.5319,"value":432974.1365,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $518.155 to $519.04, inclusive."}],"balance_after":27152,"source":{"system":"sec-edgar","filing":"0001628280-25-052411","document":"wk-form4_1763158342.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025052411/wk-form4_1763158342.xml","form_type":"4"}},{"id":999156,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-14T22:12:26.000Z","date":"2025-11-13","kind":"sale","planned":true,"acquired":false,"shares":645,"price":517.5131,"value":333795.9495,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $517.15 to $518.10, inclusive."}],"balance_after":27987,"source":{"system":"sec-edgar","filing":"0001628280-25-052411","document":"wk-form4_1763158342.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025052411/wk-form4_1763158342.xml","form_type":"4"}},{"id":999155,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-14T22:12:26.000Z","date":"2025-11-13","kind":"sale","planned":true,"acquired":false,"shares":919,"price":515.6433,"value":473876.1927,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $515.19 to $516.10, inclusive."}],"balance_after":28632,"source":{"system":"sec-edgar","filing":"0001628280-25-052411","document":"wk-form4_1763158342.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025052411/wk-form4_1763158342.xml","form_type":"4"}},{"id":999154,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-14T22:12:26.000Z","date":"2025-11-13","kind":"sale","planned":true,"acquired":false,"shares":146,"price":514.674,"value":75142.404,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $514.03 to $514.96, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below."}],"balance_after":29551,"source":{"system":"sec-edgar","filing":"0001628280-25-052411","document":"wk-form4_1763158342.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025052411/wk-form4_1763158342.xml","form_type":"4"}},{"id":999153,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-14T22:12:26.000Z","date":"2025-11-13","kind":"exercise","planned":true,"acquired":true,"shares":6000,"price":16.46,"value":98760.0,"ownership":{"direct":true},"balance_after":29697,"source":{"system":"sec-edgar","filing":"0001628280-25-052411","document":"wk-form4_1763158342.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025052411/wk-form4_1763158342.xml","form_type":"4"}},{"id":999152,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-14T22:12:26.000Z","date":"2025-11-13","kind":"exercise","planned":true,"acquired":true,"shares":2500,"price":7.36,"value":18400.0,"ownership":{"direct":true},"balance_after":23697,"source":{"system":"sec-edgar","filing":"0001628280-25-052411","document":"wk-form4_1763158342.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025052411/wk-form4_1763158342.xml","form_type":"4"}},{"id":1092519,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2025-07-03T20:39:40.000Z","date":"2025-07-01","kind":"exercise","planned":false,"acquired":false,"shares":1101,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested immediately upon grant on July 1, 2025; there was no expiration date for the RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested immediately upon grant on July 1, 2025; there was no expiration date for the RSUs."}],"balance_after":0,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":1101},"source":{"system":"sec-edgar","filing":"0001415889-25-019334","document":"form4-07032025_080736.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925019334/form4-07032025_080736.xml","form_type":"4"}},{"id":1092518,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2025-07-03T20:39:40.000Z","date":"2025-07-01","kind":"grant","planned":false,"acquired":true,"shares":1101,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested immediately upon grant on July 1, 2025; there was no expiration date for the RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested immediately upon grant on July 1, 2025; there was no expiration date for the RSUs."}],"balance_after":1101,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":1101},"source":{"system":"sec-edgar","filing":"0001415889-25-019334","document":"form4-07032025_080736.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925019334/form4-07032025_080736.xml","form_type":"4"}},{"id":1092517,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Share","published_at":"2025-07-03T20:39:40.000Z","date":"2025-07-01","kind":"exercise","planned":false,"acquired":true,"shares":1101,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":18474,"source":{"system":"sec-edgar","filing":"0001415889-25-019334","document":"form4-07032025_080736.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925019334/form4-07032025_080736.xml","form_type":"4"}},{"id":1095065,"issuer":{"id":4388,"kind":"organization","name":"Kodiak Sciences Inc."},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-07-02T20:43:59.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One hundred percent (100%) of the shares subject to the option shall vest upon the earlier of June 30, 2026 or one (1) day prior to the Issuer's next annual meeting occurring after the grant date, in each case, provided the Reporting Person continues to serve as a member of the Issuer's board of directors through the applicable vesting date."}],"balance_after":40000,"derivative":{"exercise_price":3.73,"expiration_date":"2035-06-29","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001415889-25-019086","document":"form4-07022025_080755.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468748/000141588925019086/form4-07022025_080755.xml","form_type":"4"}},{"id":1102934,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-24T20:42:30.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":1290,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests as to 100% of underlying shares on the date of the Issuer's annual meeting of stockholders to be held in 2026, provided that the Reporting Person continues to serve as a director of the Issuer until such date."}],"balance_after":1290,"derivative":{"exercise_price":285.73,"expiration_date":"2035-06-20","underlying":"Common Stock","underlying_shares":1290},"source":{"system":"sec-edgar","filing":"0001628280-25-032861","document":"wk-form4_1750797744.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025032861/wk-form4_1750797744.xml","form_type":"4"}},{"id":1102933,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T20:42:30.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":715,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units, which vest on the date of the Issuer's annual meeting of stockholders to be held in 2026, provided the Reporting Person continues in service with the Issuer on such date."}],"balance_after":21197,"source":{"system":"sec-edgar","filing":"0001628280-25-032861","document":"wk-form4_1750797744.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025032861/wk-form4_1750797744.xml","form_type":"4"}},{"id":1111494,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T20:05:20.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control."}],"balance_after":24000,"derivative":{"exercise_price":3.26,"exercise_date":"2026-06-12","expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001213900-25-054285","document":"marketforms-69815.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1454983/000121390025054285/marketforms-69815.xml","form_type":"4"}},{"id":1121415,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2025-06-05T21:05:51.000Z","date":"2025-06-05","kind":"exercise","planned":false,"acquired":false,"shares":3173,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vested in a single installment on June 5, 2025; there was no expiration date for the RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vested in a single installment on June 5, 2025; there was no expiration date for the RSUs."}],"balance_after":0,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":3173},"source":{"system":"sec-edgar","filing":"0001415889-25-015800","document":"form4-06052025_090611.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925015800/form4-06052025_090611.xml","form_type":"4"}},{"id":1121414,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2025-06-05T21:05:51.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":2799,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in their entirety on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is June 3, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in their entirety on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is June 3, 2025."}],"balance_after":2799,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":2799},"source":{"system":"sec-edgar","filing":"0001415889-25-015800","document":"form4-06052025_090611.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925015800/form4-06052025_090611.xml","form_type":"4"}},{"id":1121413,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option","published_at":"2025-06-05T21:05:51.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":16798,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of the grant with the final installment vesting on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is June 3, 2025."}],"balance_after":16798,"derivative":{"exercise_price":29.11,"expiration_date":"2035-06-02","underlying":"Class A Ordinary Shares","underlying_shares":16798},"source":{"system":"sec-edgar","filing":"0001415889-25-015800","document":"form4-06052025_090611.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925015800/form4-06052025_090611.xml","form_type":"4"}},{"id":1121412,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Share","published_at":"2025-06-05T21:05:51.000Z","date":"2025-06-05","kind":"exercise","planned":false,"acquired":true,"shares":3173,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":17373,"source":{"system":"sec-edgar","filing":"0001415889-25-015800","document":"form4-06052025_090611.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925015800/form4-06052025_090611.xml","form_type":"4"}},{"id":1142554,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-19T20:10:10.000Z","date":"2025-05-14","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":3.19,"value":63800.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.15 to $3.22, inclusive. The reporting person undertakes to provide to TARA, any security holder of TARA, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":51000,"source":{"system":"sec-edgar","filing":"0001213900-25-045399","document":"marketforms-69540.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1454983/000121390025045399/marketforms-69540.xml","form_type":"4/A","original_submission_date":"2025-05-16"}},{"id":1145217,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-16T20:05:07.000Z","date":"2025-05-14","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":3.19,"value":63800.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.15 to $3.22, inclusive. The reporting person undertakes to provide to TARA, any security holder of TARA, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":51000,"source":{"system":"sec-edgar","filing":"0001213900-25-044871","document":"marketforms-69472.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1454983/000121390025044871/marketforms-69472.xml","form_type":"4"}},{"id":1173492,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-11T20:59:35.000Z","date":"2025-04-10","kind":"exercise","planned":false,"acquired":false,"shares":9470,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this stock option are fully vested and exercisable"}],"balance_after":0,"derivative":{"exercise_price":65.06,"expiration_date":"2025-06-16","underlying":"Common Stock","underlying_shares":9470},"source":{"system":"sec-edgar","filing":"0001628280-25-017563","document":"wk-form4_1744405167.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025017563/wk-form4_1744405167.xml","form_type":"4"}},{"id":1173491,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-11T20:59:35.000Z","date":"2025-04-10","kind":"exercise","planned":false,"acquired":true,"shares":9470,"price":65.06,"value":616118.2,"ownership":{"direct":true},"balance_after":20482,"source":{"system":"sec-edgar","filing":"0001628280-25-017563","document":"wk-form4_1744405167.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025017563/wk-form4_1744405167.xml","form_type":"4"}},{"id":1369049,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2024-11-12T21:35:04.000Z","date":"2024-11-07","kind":"exercise","planned":false,"acquired":false,"shares":1303,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested immediately upon grant on November 7, 2024; there was no expiration date for the RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested immediately upon grant on November 7, 2024; there was no expiration date for the RSUs."}],"balance_after":0,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":1303},"source":{"system":"sec-edgar","filing":"0001415889-24-026617","document":"form4-11122024_091100.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588924026617/form4-11122024_091100.xml","form_type":"4"}},{"id":1369048,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2024-11-12T21:35:04.000Z","date":"2024-11-07","kind":"grant","planned":false,"acquired":true,"shares":1303,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested immediately upon grant on November 7, 2024; there was no expiration date for the RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested immediately upon grant on November 7, 2024; there was no expiration date for the RSUs."}],"balance_after":1303,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":1303},"source":{"system":"sec-edgar","filing":"0001415889-24-026617","document":"form4-11122024_091100.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588924026617/form4-11122024_091100.xml","form_type":"4"}},{"id":1369047,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Share","published_at":"2024-11-12T21:35:04.000Z","date":"2024-11-07","kind":"exercise","planned":false,"acquired":true,"shares":1303,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":14200,"source":{"system":"sec-edgar","filing":"0001415889-24-026617","document":"form4-11122024_091100.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588924026617/form4-11122024_091100.xml","form_type":"4"}},{"id":1371732,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-11-08T22:07:14.000Z","date":"2024-11-07","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option are fully vested and exercisable."}],"balance_after":5000,"derivative":{"exercise_price":7.36,"expiration_date":"2026-08-11","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000950170-24-124232","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017024124232/ownership.xml","form_type":"4"}},{"id":1371731,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-08T22:07:14.000Z","date":"2024-11-07","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":350,"value":1750000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2023."}],"balance_after":11012,"source":{"system":"sec-edgar","filing":"0000950170-24-124232","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017024124232/ownership.xml","form_type":"4"}},{"id":1371730,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-08T22:07:14.000Z","date":"2024-11-07","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":7.36,"value":36800.0,"ownership":{"direct":true},"balance_after":16012,"source":{"system":"sec-edgar","filing":"0000950170-24-124232","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017024124232/ownership.xml","form_type":"4"}},{"id":1375789,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-11-06T00:01:47.000Z","date":"2024-11-01","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares underlying this option are fully vested and exercisable."}],"balance_after":10000,"derivative":{"exercise_price":7.36,"expiration_date":"2026-08-11","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000950170-24-121722","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017024121722/ownership.xml","form_type":"4"}},{"id":1375788,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-06T00:01:47.000Z","date":"2024-11-01","kind":"sale","planned":true,"acquired":false,"shares":300,"price":304.291,"value":91287.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $303.99 to $304.55, inclusive."}],"balance_after":11012,"source":{"system":"sec-edgar","filing":"0000950170-24-121722","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017024121722/ownership.xml","form_type":"4"}},{"id":1375787,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-06T00:01:47.000Z","date":"2024-11-01","kind":"sale","planned":true,"acquired":false,"shares":800,"price":302.2488,"value":241799.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $302.11 to $302.30, inclusive."}],"balance_after":11312,"source":{"system":"sec-edgar","filing":"0000950170-24-121722","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017024121722/ownership.xml","form_type":"4"}},{"id":1375786,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-06T00:01:47.000Z","date":"2024-11-01","kind":"sale","planned":true,"acquired":false,"shares":1100,"price":301.2173,"value":331339.03,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $301.00 to $301.76, inclusive."}],"balance_after":12112,"source":{"system":"sec-edgar","filing":"0000950170-24-121722","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017024121722/ownership.xml","form_type":"4"}},{"id":1375785,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-06T00:01:47.000Z","date":"2024-11-01","kind":"sale","planned":true,"acquired":false,"shares":2800,"price":300.0993,"value":840278.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $300.00 to $300.44, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below."}],"balance_after":13212,"source":{"system":"sec-edgar","filing":"0000950170-24-121722","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017024121722/ownership.xml","form_type":"4"}},{"id":1375784,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-06T00:01:47.000Z","date":"2024-11-01","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":7.36,"value":36800.0,"ownership":{"direct":true},"balance_after":16012,"source":{"system":"sec-edgar","filing":"0000950170-24-121722","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017024121722/ownership.xml","form_type":"4"}},{"id":1465731,"issuer":{"id":4388,"kind":"organization","name":"Kodiak Sciences Inc."},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-01T22:23:02.000Z","date":"2024-06-28","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One hundred percent (100%) of the shares subject to the option shall vest upon the earlier of June 28, 2025 or one (1) day prior to the Issuer's next annual meeting occurring after the grant date, in each case, provided the Reporting Person continues to serve as a member of the Issuer's board of directors through the applicable vesting date."}],"balance_after":40000,"derivative":{"exercise_price":2.35,"expiration_date":"2034-06-27","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001415889-24-018661","document":"form4-07012024_100759.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468748/000141588924018661/form4-07012024_100759.xml","form_type":"4"}},{"id":1468296,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-28T01:42:09.000Z","date":"2024-06-25","kind":"grant","planned":false,"acquired":true,"shares":1105,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests as to 100% of underlying shares on the first anniversary of the grant date, provided that the Reporting Person continues to serve as a director of the Issuer until such anniversary date."}],"balance_after":1105,"derivative":{"exercise_price":280.04,"expiration_date":"2031-06-25","underlying":"Common Stock","underlying_shares":1105},"source":{"system":"sec-edgar","filing":"0000950170-24-078749","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017024078749/ownership.xml","form_type":"4"}},{"id":1468295,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-28T01:42:09.000Z","date":"2024-06-25","kind":"grant","planned":false,"acquired":true,"shares":714,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units, which vest on June 25, 2025, provided the Reporting Person continues in service with the Issuer on such date."}],"balance_after":11012,"source":{"system":"sec-edgar","filing":"0000950170-24-078749","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017024078749/ownership.xml","form_type":"4"}},{"id":1484792,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-10T22:00:18.000Z","date":"2024-06-07","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control."}],"balance_after":10000,"derivative":{"exercise_price":2.67,"expiration_date":"2034-06-06","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001213900-24-051378","document":"marketforms-66261.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1454983/000121390024051378/marketforms-66261.xml","form_type":"4"}},{"id":1486900,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2024-06-07T20:40:13.000Z","date":"2024-06-06","kind":"exercise","planned":false,"acquired":false,"shares":4373,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vested in a single installment on June 6, 2024; there was no expiration date for the RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vested in a single installment on June 6, 2024; there was no expiration date for the RSUs."}],"balance_after":0,"derivative":{"underlying":"Class A Common Shares","underlying_shares":4373},"source":{"system":"sec-edgar","filing":"0001415889-24-016006","document":"form4-06072024_080609.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588924016006/form4-06072024_080609.xml","form_type":"4"}},{"id":1486899,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2024-06-07T20:40:13.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":3173,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in their entirety on the first anniversary date of the grant, June 5, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in their entirety on the first anniversary date of the grant, June 5, 2024."}],"balance_after":3173,"derivative":{"underlying":"Class A Common Shares","underlying_shares":3173},"source":{"system":"sec-edgar","filing":"0001415889-24-016006","document":"form4-06072024_080609.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588924016006/form4-06072024_080609.xml","form_type":"4"}},{"id":1486898,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option","published_at":"2024-06-07T20:40:13.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":19040,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of the grant. The date of the grant is June 5, 2024."}],"balance_after":19040,"derivative":{"exercise_price":19.71,"expiration_date":"2034-06-04","underlying":"Class A Common Shares","underlying_shares":19040},"source":{"system":"sec-edgar","filing":"0001415889-24-016006","document":"form4-06072024_080609.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588924016006/form4-06072024_080609.xml","form_type":"4"}},{"id":1486897,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Share","published_at":"2024-06-07T20:40:13.000Z","date":"2024-06-06","kind":"exercise","planned":false,"acquired":true,"shares":4373,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer."}],"balance_after":12897,"source":{"system":"sec-edgar","filing":"0001415889-24-016006","document":"form4-06072024_080609.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588924016006/form4-06072024_080609.xml","form_type":"4"}},{"id":1524806,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2024-05-07T20:46:15.000Z","date":"2024-05-03","kind":"exercise","planned":false,"acquired":false,"shares":747,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested immediately upon grant on May 3, 2024; there was no expiration date for the RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested immediately upon grant on May 3, 2024; there was no expiration date for the RSUs."}],"balance_after":0,"derivative":{"underlying":"Class A Common Shares","underlying_shares":747},"source":{"system":"sec-edgar","filing":"0001415889-24-012480","document":"form4-05072024_080507.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588924012480/form4-05072024_080507.xml","form_type":"4"}},{"id":1524805,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2024-05-07T20:46:15.000Z","date":"2024-05-03","kind":"grant","planned":false,"acquired":true,"shares":747,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested immediately upon grant on May 3, 2024; there was no expiration date for the RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested immediately upon grant on May 3, 2024; there was no expiration date for the RSUs."}],"balance_after":747,"derivative":{"underlying":"Class A Common Shares","underlying_shares":747},"source":{"system":"sec-edgar","filing":"0001415889-24-012480","document":"form4-05072024_080507.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588924012480/form4-05072024_080507.xml","form_type":"4"}},{"id":1524804,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Share","published_at":"2024-05-07T20:46:15.000Z","date":"2024-05-03","kind":"exercise","planned":false,"acquired":true,"shares":747,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer."}],"balance_after":8524,"source":{"system":"sec-edgar","filing":"0001415889-24-012480","document":"form4-05072024_080507.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588924012480/form4-05072024_080507.xml","form_type":"4"}},{"id":1550634,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-04T00:47:46.000Z","date":"2024-04-01","kind":"exercise","planned":true,"acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The shares underlying this option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":111.06,"expiration_date":"2025-06-17","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0000950170-24-041528","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017024041528/ownership.xml","form_type":"4"}},{"id":1550633,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-04T00:47:46.000Z","date":"2024-04-01","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The shares underlying this option are fully vested and exercisable."}],"balance_after":15000,"derivative":{"exercise_price":7.36,"expiration_date":"2026-08-11","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000950170-24-041528","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017024041528/ownership.xml","form_type":"4"}},{"id":1550632,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-04T00:47:46.000Z","date":"2024-04-01","kind":"sale","planned":true,"acquired":false,"shares":300,"price":267.0733,"value":80121.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $266.73 to $267.25, inclusive."}],"balance_after":10298,"source":{"system":"sec-edgar","filing":"0000950170-24-041528","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017024041528/ownership.xml","form_type":"4"}},{"id":1550631,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-04T00:47:46.000Z","date":"2024-04-01","kind":"sale","planned":true,"acquired":false,"shares":713,"price":265.2809,"value":189145.2817,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $264.65 to $265.64, inclusive."}],"balance_after":10598,"source":{"system":"sec-edgar","filing":"0000950170-24-041528","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017024041528/ownership.xml","form_type":"4"}},{"id":1550630,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-04T00:47:46.000Z","date":"2024-04-01","kind":"sale","planned":true,"acquired":false,"shares":100,"price":259.07,"value":25907.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2023."}],"balance_after":11311,"source":{"system":"sec-edgar","filing":"0000950170-24-041528","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017024041528/ownership.xml","form_type":"4"}},{"id":1550629,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-04T00:47:46.000Z","date":"2024-04-01","kind":"sale","planned":true,"acquired":false,"shares":1600,"price":257.9347,"value":412695.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $257.54 to $258.465, inclusive."}],"balance_after":11411,"source":{"system":"sec-edgar","filing":"0000950170-24-041528","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017024041528/ownership.xml","form_type":"4"}},{"id":1550628,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-04T00:47:46.000Z","date":"2024-04-01","kind":"sale","planned":true,"acquired":false,"shares":3900,"price":256.881,"value":1001835.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $256.45 to $257.40, inclusive."}],"balance_after":13011,"source":{"system":"sec-edgar","filing":"0000950170-24-041528","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017024041528/ownership.xml","form_type":"4"}},{"id":1550627,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-04T00:47:46.000Z","date":"2024-04-01","kind":"sale","planned":true,"acquired":false,"shares":4387,"price":255.899,"value":1122628.913,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $255.42 to $256.41, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below."}],"balance_after":16911,"source":{"system":"sec-edgar","filing":"0000950170-24-041528","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017024041528/ownership.xml","form_type":"4"}},{"id":1550626,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-04T00:47:46.000Z","date":"2024-04-01","kind":"exercise","planned":true,"acquired":true,"shares":6000,"price":111.06,"value":666360.0,"ownership":{"direct":true},"balance_after":21298,"source":{"system":"sec-edgar","filing":"0000950170-24-041528","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017024041528/ownership.xml","form_type":"4"}},{"id":1550625,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-04T00:47:46.000Z","date":"2024-04-01","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":7.36,"value":36800.0,"ownership":{"direct":true},"balance_after":15298,"source":{"system":"sec-edgar","filing":"0000950170-24-041528","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017024041528/ownership.xml","form_type":"4"}},{"id":1747688,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2023-11-07T21:33:10.000Z","date":"2023-11-03","kind":"exercise","planned":false,"acquired":false,"shares":2777,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested immediately upon grant on November 3, 2023; there was no expiration date for the RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested immediately upon grant on November 3, 2023; there was no expiration date for the RSUs."}],"balance_after":0,"derivative":{"underlying":"Class A Common Shares","underlying_shares":2777},"source":{"system":"sec-edgar","filing":"0001415889-23-014841","document":"form4-11072023_091100.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588923014841/form4-11072023_091100.xml","form_type":"4"}},{"id":1747687,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2023-11-07T21:33:10.000Z","date":"2023-11-03","kind":"grant","planned":false,"acquired":true,"shares":2777,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested immediately upon grant on November 3, 2023; there was no expiration date for the RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested immediately upon grant on November 3, 2023; there was no expiration date for the RSUs."}],"balance_after":2777,"derivative":{"underlying":"Class A Common Shares","underlying_shares":2777},"source":{"system":"sec-edgar","filing":"0001415889-23-014841","document":"form4-11072023_091100.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588923014841/form4-11072023_091100.xml","form_type":"4"}},{"id":1747686,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Share","published_at":"2023-11-07T21:33:10.000Z","date":"2023-11-03","kind":"exercise","planned":false,"acquired":true,"shares":2777,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer."}],"balance_after":7777,"source":{"system":"sec-edgar","filing":"0001415889-23-014841","document":"form4-11072023_091100.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588923014841/form4-11072023_091100.xml","form_type":"4"}},{"id":1839604,"issuer":{"id":4388,"kind":"organization","name":"Kodiak Sciences Inc."},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-03T20:26:31.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One hundred percent (100%) of the shares subject to the option shall vest upon the earlier of June 30, 2024 or one (1) day prior to the Issuer's next annual meeting occurring after the grant date, in each case, provided the Reporting Person continues to serve as a member of the Issuer's board of directors through the applicable vesting date."}],"balance_after":40000,"derivative":{"exercise_price":6.9,"expiration_date":"2033-06-29","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-23-040585","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468748/000120919123040585/doc4.xml","form_type":"4"}}],"next_cursor":"2023-07-03T20:26:31.000000Z,1839604"}